MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
M

Management of Advanced CSCC: EMPOWER-CSCC-1 Study

By MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020 FEATURING Michael Migden
By MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020 FEATURING Michael Migden
226 views
November 19, 2020
Comments 0
Login to view comments. Click here to Login

Recommended

17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views
09:00

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

758 views
11:53

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

287 views
21:20

Year in Review: Updates in Non-Melanoma Skin Cancers

Dana-Farber Cancer Institute

K. Khaddour

270 views
26:24

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

429 views
13:21

Management of High Risk Squamous Cell Carcinoma

NYU Langone

M. L. Stevenson

457 views
13:59

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

140 views
05:58

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC …

Insights from 2023 ESMO Annual Meeting

N. Gross

193 views
58:44

Updates in non-Melanoma Skin Cancer

Head and Neck Symposium: Skin Malignancies Update

S. Daveluy

213 views
15:39

Neoadjuvant IO: Non-Melanoma Skin Cancer

ImmunoTherapy Bridge 2023

N. Gross

141 views
47:34

Fred Hutchinson Cancer Center Head & Neck Cancer Updates

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

C. Rodriguez

397 views
15:54

Non-Melanoma Skin Cancers

ImmunoTherapy Bridge 2023

P. A. Ascierto

124 views
27:29

2023 ASCO® Direct Philadelphia: Melanoma Updates

Total Health

M. Orloff

133 views
23:44

PD-1 Inhibitors for Advanced Basal Cell Carcinoma and Squamous Cell …

Todd Schlesinger

347 views
24:20

ASCO® 2023 Insights: "To Treat or Not to Treat - Challenging Scenari…

Insights from 2023 ASCO® Annual Meeting

K. Margolin

186 views
02:41

ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplimab in …

ecancer

N. Gross

104 views
12:13

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…

AACR 2023 Conference Coverage

E. Cohen

206 views
18:56

Immunotherapy and Anti-Angiogenic Therapies in HNSCC

Yale Cancer Center

A. Bhatia

263 views
09:00

Harnessing IO in the Management of CSCC

Winship Cancer Institute - Emory University

N. Saba

105 views
25:33

Update on HPV Testing in Head and Neck Cancer

Houston Methodist

M. R. Schwartz

198 views
AUTOPLAY